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BACKGROUND: Soft tissue infections (STIs) from injec-
tion drug use are a common cause of Emergency
Department visits, hospitalizations, and operating room
procedures, yet little is known about factors that may
predict the need for these costly medical services.
OBJECTIVE: To describe a cohort of injection drug
users seeking Emergency Department care for STIs and
to identify risk factors associated with hospitalization.
We hypothesized that participants who delayed seeking
care would be hospitalized more often than those who
did not.
DESIGN: Cohort study using in-person structured
interviews and medical record review. Logistic regres-
sion assessed the association between hospital admis-
sion and delay in seeking care as well as other
demographic, clinical, and psychosocial factors.
PARTICIPANTS: Injection drug users who sought
Emergency Department care for STIs from May 2001
to March 2002.
RESULTS: Of the 136 participants, 55 (40%) were
admitted to the hospital. Delay in seeking care was not
associated with hospital admission. Participants admit-
ted for their infection were significantly more likely to be
living in a shelter (P=.01) and to report being hospital-
ized 2 or more times in the past year (P<.01).
CONCLUSIONS: We identified a subpopulation of injec-
tion drug users, mostly living in shelters, who were
hospitalized frequently in the past year and who were
more likely to be hospitalized for their current infections
compared to others. As members of this subpopulation
can be easily identified and located, they may benefit
from interventions to reduce the health care utilization
resulting from these infections.
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BACKGROUND
Injection drug use has many well-recognized adverse effects on
health including overdose, withdrawal, viral hepatitis, HIV,
endocarditis, and infections of skin and soft tissues. Soft
tissue infections (STIs) are particularly common, affecting up
to 32% of injection drug users at a given time.
1 These
infections are painful and costly to patients and may progress
to more serious life- and limb-threatening infections.
2,3 The
growing epidemic of methicillin-resistant Staphylococcus aure-
us STIs, particularly among injection drug users, has compli-
cated treatment of these infections.
4–7
For urban hospitals that serve a large number of uninsured
or publicly insured patients, injection drug use–related STIs
consume significant resources in Emergency Departments,
inpatient wards, and operating rooms. For example, STIs
accounted for more than 3,000 Emergency Department visits
to San Francisco General Hospital in 1999 and were the most
common reason for nonpsychiatric hospitalization. Abscess
incision and drainage was the most common primary proce-
dure for all inpatients.
8 Based on medical record reviews, 70%
of the infections resulted from injection drug use, and annual
Emergency Department and inpatient costs of treating the
infections were estimated at 20 million dollars.
8 Similarly, at
Detroit Receiving Hospital more than 20 years ago, inpatient
costs for the care of injection drug use–related abscesses alone
were 6.9 million dollars for 1 year.
9 A community-recruited
cohort of 598 injection drug users in Vancouver, British
Columbia experienced 2,763 Emergency Department visits
and 495 admissions to 1 hospital in a 40-month period, and
STI was the most common admission and Emergency Depart-
ment diagnosis for those patients.
10 A medical record review
conducted at the same hospital as the present study docu-
mented that approximately 39% of injection drug users who
sought care for STIs in the Emergency Department were
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382hospitalized for treatment of their infections.
11 Despite this
research showing the burden of injection drug use–related
STIs, no study has evaluated potentially modifiable risk factors
that might be associated with more severe STIs that require
hospitalization.
We sought to describe a cohort of injection drug users
seeking Emergency Department care for STIs at an urban,
public hospital in Washington State and to identify modifiable
risk factors associated with hospitalization. In particular, we
hypothesized a priori that participants who delayed seeking
care for their STIs would be hospitalized more often than those
who did not delay seeking care. We also sought to identify any
other patient-related or environmental barriers to care that
were associated with a delay in seeking care and subsequent
need for hospitalization (Fig. 1). For participants with abscess-
es, we assessed the association between these barriers to care
and need for operating room incision and drainage.
METHODS
Study Design
This cohort study used in-person interviews and hospital
records of injection drug users seeking Emergency Department
care for STIs. The institutional review board approved study
procedures, including written informed consent and acquisi-
tion of a certificate of confidentiality from the National
Institutes of Health.
Setting
Recruitment of participants was conducted at an urban,
county hospital Emergency Department in Washington State,
from May 2001 to March 2002. Participants were interviewed
during their Emergency Department visit when possible.
However, some interviews were completed after hospital ad-
mission or discharge from the Emergency Department.
Participants
Eligible patients were English-speaking injection drug users
who were seeking initial care for a STI and who agreed to a 45-
minute interview and review of their hospital records. Emer-
gency Department providers identified potential subjects and
assessed their willingness and ability to participate in the
study. Four trained research assistants spent an average of
59 hours per week interviewing participants between 8 A.M.
and 10 P.M. Based on a previously published medical record
review that identified 242 injection drug users seeking care for
Figure 1. Hypothesized relationships between barriers to seeking care, delay in seeking care, soft tissue infection severity, and Emergency
Department (ED) disposition.
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period in 1999–2000, we estimated that approximately 409
injection drug users would seek Emergency Department care
for STIs during the 44-week interview period, with most
patients presenting between 8 A.M. and 10 P.M..
11 In the
present study, Emergency Department staff identified 211
eligible patients who were able and agreed to speak to a
research assistant and of those, 156 (74%) agreed to partici-
pate and completed the interview. Those who completed the
interview were remunerated with a $20 gift certificate for
groceries. We excluded 20 participants who left the Emergency
Department against medical advice or before completion of
their medical evaluation, reducing the study population to 136
patients.
Data Collection
We developed a semistructured interview instrument to spe-
cifically assess whether participants delayed seeking medical
care, our hypothesized predictor of hospitalization. In addition,
the interview sought information about factors hypothesized to
affect STI severity or present barriers to seeking medical care,
resulting in a delay in seeking care. These questions spanned 5
domains: (1) illicit drug use and behaviors (2) current STI
characteristics, (3) health care utilization and access to care,
(4) general health, medical comorbidity and psychiatric symp-
toms, and (5) sociodemographic characteristics. Previously
used measures were incorporated when available (described
below). Interviewers utilized calendars and other visual
prompts shown previously to improve recall reliability in
patients with substance abuse problems.
12
In addition to interview data, the hospital electronic medical
record system was accessed to obtain information on patients’
Emergency Department treatment, insurance status, surgical
procedures, and hospitalizations.
Measures
Hospital Utilization. Hospital admission for an STI was selected
as this study’s a priori primary outcome, because it reflects STI
severity as well as the burden of the STI on the patient and
society. Whether or not patients were hospitalized was
obtained from hospital records. For patients with abscesses,
a secondary outcome of whether incision and drainage was
performed in the operating room versus at the bedside in the
Emergency Department or hospital room was also obtained
from hospital records.
Delay in Seeking Care. Several measures of delay in seeking
care were assessed. First, participants were asked to explicitly
report whether they had delayed seeking medical care for their
current STIs, and if so, for how many days (0, 1–3, 4–7, or
more than 7). Second, participants were asked about the
timing of signs and symptoms of infection as another means
of assessing potential delay in seeking care. Specifically, they
were asked if they had any systemic (fevers, high temperature,
or sore muscles) or local (redness, warmth, swelling, drainage,
or pain) signs or symptoms of infection. Those who reported
any signs or symptoms of infection were then asked to
estimate the number of days they had had each sign or
symptom (0, 1–3, 4–7, or more than 7).
Access to Health Care. To assess potential barriers to care,
participants were asked about their previous experiences with
the health care system, including whether they had a primary
care provider and the number of times they were hospitalized
in the past year. Participants’ insurance or health benefits
were ascertained from hospital records.
Drug Use History and Behaviors. Drugusehistoryandbehaviors
were assessed using questions from previous epidemiologic
studies of illicit drug users whenever possible.
13,14 Participants
were asked about their last drug injection, including the type of
drug they injected (heroin, cocaine, heroin and cocaine,
amphetamines), whether they injected into a vein, sub-
cutaneously, intramuscularly, or missed a vein, and their skin
and syringe-cleaning behaviors. Number of years of injection
drug use (0–9, 10–19, 20–29, or 30–41), the drug(s) participants
injected most frequently, and their skin, syringe, and needle-
cleaning behaviors were also ascertained from interviews. The
AUDIT-C alcohol screening questionnaire was used to assess
alcohol misuse, including risky drinking and alcohol use dis-
orders.
15 An AUDIT-C score of 4 or more was considered a pos-
itive screen for alcohol misuse.
16
Soft Tissue Infection Characteristics. The type, location, and
number of current STIs were determined by review of
Emergency Department documentation and interviews. STIs
were categorized as being abscesses, cellulitis, or infected
ulcers. Infections were considered abscesses if an incision
and drainage procedure yielded purulent material or if
spontaneous drainage of an infection was reported by the
patient or in provider notes. STI locations were grouped
according to the following anatomic sites: shoulder, arm, leg,
buttock, 2 or more sites, and other sites. Participants were
asked to estimate the number of previous STIs they had
experienced and to describe prior self-treatment of their
current infection, including use of antibiotics and incision
and drainage attempts.
General Health, Medical Comorbidity and Psychiatric
Symptoms. Participants’ overall health status (poor, fair,
good, very good, excellent) was based on self-report.
Psychiatric symptoms were assessed using the psychiatric
status section of the Addiction Severity Index (ASI). Psychiatric
status composite scores were calculated using the formulas
supplied by the ASI Composite Scores Manual
17 and could
range from 0 to 1 with higher scores indicating a higher
“severity rating.”
Sociodemographic Characteristics. During the interview,
participants were asked about their current living situation
(own or rent a house or apartment; someone else’s house or
apartment; hotel, motel, boarding house, halfway house;
shelter; on the streets, car, or abandoned building; other) and
whether they considered themselves homeless. They were
384 Takahashi et al.: Injection Drug Users Seeking Care JGIMasked about their level of education, employment status, and
whether they had ever been incarcerated.
Statistical Analyses
Initially, the relationship between measures of delay in seeking
care and the study’s primary outcome, hospitalization, was
assessed with bivariate logistic regression. Secondary explor-
atory bivariate analyses using logistic regression explored
whether study participants’ drug use history and behaviors,
STI characteristics, previous health care utilization, medical
comorbidity, psychiatric symptoms, and sociodemographic
characteristics were associated with hospital admission. We
then constructed a multivariable logistic regression model that
included all factors significantly associated with hospitaliza-
tion on bivariate analyses to determine their independent
relationship with hospitalization. Associations with p values
<.05 were considered statistically significant.
Similarly, for participants who had injection drug use–
related abscesses, we used bivariate logistic regression to
assess the relationship between need for operating room
incision and drainage and measures of delay in seeking care.
Exploratory bivariate analyses were used to explore whether
particular drug use history and behaviors, STI characteristics,
previous health care utilization, medical comorbidity and
psychiatric symptoms, and sociodemographic characteristics
predicted operating room incision and drainage. Factors that
were significantly associated with operating room incision and
drainage on bivariate analyses (P<.05) were included in a
multivariable logistic regression model to test their indepen-
dent association with operating room incision and drainage.
Statistical analyses were performed using STATA statistical
software (STATA Corp, College Station, TX).
RESULTS
A total of 136 patients who sought initial care for 147 soft
tissue infections in the Emergency Department consented to
participate and completed the in-person interview and their
medical evaluation (Table 1). Although more than 75% of
participants reported that they graduated from high school or
obtained their general educational development (GED) creden-
tial , only 11% reported having a job and nearly one-third lived
on the streets or in shelters. The 136 study participants had a
total of 147 infections and the characteristics of their infec-
tions are presented in Table 2.
Of the 136 participants, 55 (40%) were admitted to the
hospital. Contrary to our hypothesis, this study’sm e a s u r e s
of delay in seeking care were not associated with hospitali-
zation. Patients who were admitted to the hospital did differ
in their previous health care utilization and current living
situation compared to those who were not admitted. Specif-
ically, participants who were hospitalized for treatment of
their STIs were significantly more likely to report being
hospitalized 2 or more times in the past year and to be living
in a shelter compared to those treated as outpatients
(Table 3). The type and location of infection and other demo-
graphic characteristics presented in Table 1 were not associated
with hospitalization.
Table 1. Study Population Characteristics
Demographics Discharged
from ED
Hospitalized Total
Sample
P
value
N=81 N (%) N=55 N (%) N=136* N (%)
Mean age, (SD), yrs 43 (8) 41 (8) 43 (8) .19
Female 28 (35) 24 (44) 52 (38) .22
Non-Hispanic White 49 (60) 36 (65) 85 (63) .52
Living situation .05
Owns/rents home 28 (35) 13 (24) 41 (30)
Street 15 (19) 11 (20) 26 (19)
Living in a shelter 5 (6) 13 (24) 18 (13)
Other
† 33 (41) 18 (33) 51 (38)
Graduated from high
school/GED
‡
62 (77) 42 (76) 104 (76) .97
Currently employed 9 (11) 6 (11) 15 (11) 1.00
Reported time in jail,
prison, or juvenile
detention
71 (88) 41 (75) 112 (82) .18
Health care utilization
and access to care
Two or more hospital-
zations past year
7 (9) 18 (33) 25 (18) <.01
Insurance benefits .96
Medicare/Medicaid 40 (49) 39 (71) 79 (58)
Self Pay 13 (16) 13 (24) 29 (19)
Other/Unknown 28 (35) 3 (5) 31 (23)
Has a primary care
provider
37 (46) 19 (35) 56 (41) .26
Delay in seeking care
Considered coming in
for the infection
before today
63 (78) 43 (78) 106 (78) .80
One or more days of
ANY symptoms
59 (73) 42 (76) 101 (74) .30
One or more days
of SYSTEMIC
§
symptoms
64 (79) 50 (91) 114 (84) .30
Drug use history and behaviors
Reported 10 or more
years of injection
drug use
59 (73) 40 (73)
|| 99 (73)
|| .99
Last injection site .66
Vein 7 (9) 5 (9) 12 (9)
Muscle 32 (40) 22 (40) 54 (40)
Other 42 (52) 28 (51) 70 (51)
Most frequently injected
drug is heroin only
68 (84) 51 (93) 119 (88) .07
Reported using a
needle exchange
program
70 (86) 51 (93) 121 (89) .14
Did not clean skin
before last injection
33 (41) 23 (42) 56 (41) .90
Hazardous drinking
(AUDIT-C score >4)
25 (31) 13 (24) 38 (28) .34
General health, medical comorbidity, and psychiatric symptoms
My health is poor 17 (21) 14 (25) 31 (23) .51
Median ASI Psychiatric
Status composite
score (range)
0.5 (0–1) 0.4(0–0.8) 0.4 (0–1) .08
*Excludes subjects with missing data and 20 subjects who left the ED
against medical advice or prior to medical evaluation.
†Someone else’s house or apartment, hotel/motel, boarding house, half-
way house.
‡General educational development credential.
§Fevers, chills, muscle aches.
||Percentages do not sum to 100% due to missing values.
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The subgroup of 25 participants who reported being hospital-
ized 2 or more times in the past year comprised 18% of the
overall study population and 33% of those hospitalized for
treatment of their STIs. Whereas 72% of this subgroup was
admitted for their current infection, only 33% of the rest of the
study population was admitted. No participant in this sub-
group reported being employed. Based on exploratory logistic
regression analyses, living in a shelter and injecting drugs for
30 years or more were independently associated with being
hospitalized 2 or more times in the past year (Table 4). The type
and location of infection and other demographic character-
istics presented in Table 1 were not associated with being
hospitalized 2 or more times in the past year.
Patients with Abscesses
Among the 101 (69%) participants with abscesses, 60% had
their infection incised and drained at the bedside, whereas
23% were incised and drained in the operating room and 3%
had incision and drainage procedures both at the bedside and
in the operating room. Ten percent had abscesses that had
drained previously, either spontaneously or by self-incision
and drainage and 4% of participants had suspected abscesses
that were not drained. On unadjusted analyses, participants
who reported having systemic symptoms for more than 7 days
were more likely to undergo operating room incision and
drainage compared to those reporting no systemic symptoms
(odds ratio [OR] 6.0, 95% CI 1.1–33.3) and participants with
abscesses in the shoulder region were more likely to undergo
operating room incision and drainage compared to those with
abscesses in other areas (OR 3.0, 95% CI 1.1–8.1). In a
multivariable model, only the location of the abscess in the
shoulder region independently predicted operating room inci-
sion and drainage (OR 3.1, 95% CI 1.1–8.9).
DISCUSSION
Many injection drug users with STIs seek care in emergency
departments [
10], and many are subsequently hospitalized [
11].
We hypothesized that a delay in seeking care might be a
modifiable risk factor for hospital admission and more severe
abscesses requiring operating room incision and drainage.
This study’s measures of delay in seeking care included
participants’ self-report of delay, their estimated duration of
delay, and the duration of any signs and symptoms of
infection. Contrary to our hypothesis, none of these measures
of delay were associated with hospitalization or operating room
incision and drainage.
This study also prospectively evaluated the association of
patient characteristics, including potentially modifiable risk
factors, with hospital admission for an injection drug use–
Table 2. Current Soft Tissue Infection Characteristics
Discharged
from ED N=81
Hospitalized
N=55
Total
Sample
N=136*
P
value
Type of soft
tissue infection
.79
Abscess 58 (72) 43 (78) 101 (74)
Only cellulites 15 (19) 8 (15) 23 (17)
Infected
ulcer/unknown
8 (10) 4 (6) 12 (9)
Location of soft
tissue infection
.74
Shoulder region 12 (15) 9 (16) 21 (15)
Arm (excluding
shoulder region)
30 (37) 15 (27) 45 (33)
Leg 17 (21) 11 (20) 28 (21)
Buttock 11 (14) 11 (20) 22 (16)
Other locations/
multiple sites
11 (14) 9 (16) 20 (15)
More than 1 current STI 42 (52) 27 (49) 69 (51) .75
Self-treatment with
oral antibiotics
21 (26) 14 (25) 35 (26) 1.00
Self-treatment with
incision and drainage
33 (41) 22 (40) 55 (40) 1.00
* Excludes subjects with missing data and 20 subjects who left the ED
against medical advice prior to medical evaluation.
Table 3. Predictors of Hospitalization for Sti from the Emergency
Department
Odds Ratio (95% Confidence Interval)
Bivariate Multivariate
Living situation
Owns or rents a home Reference Reference
Lives in a shelter 5.6 (1.6–19.0) 4.2 (1.2–15.1)
Lives on the streets 1.6 (0.6–4.4) 1.4 (0.5–4.1)
Other* 1.0 (0.4–2.5) 1.1 (0.5–2.8)
Hospitalized 2 or more times in the past year
No Reference Reference
Yes 2.7 (0.9–7.7) 4.4 (1.6–11.8)
*Someone else’s house or apartment, hotel/motel, boarding house,
half-way house.
Table 4. Predictors of being Hospitalized Two or More Times in the
Past Year
Odds Ratio (95% Confidence
Interval)
Bivariate Multivariate
Reported current living situation
Owns/rents a home Reference Reference
Lives in a shelter 4.7 (1.3–16.6) 4.5 (1.1–19.2)
Lives on the streets 1.8 (0.5–6.2) 2.2 (0.6–8.7)
Other* 0.7 (0.2–2.4) 0.96 (0.2–3.5)
Reported years of injection drug
use
0–9 Reference Reference
1–19 0.7 (0.2–3.3) 0.7 (0.1–3.9)
20–29 1.4 (0.3–5.9) 1.4 (0.3–6.3)
30–41 5.2 (1.4–18.4) 4.3 (1.1–16.8)
Reported chronic medical problems 2.6 (1.0–6.6) 2.2 (0.8–6.3)
More than 1 current soft tissue
infection
2.5 (1.0–6.2) 2.6 (0.9–7.4)
*Someone else’s house or apartment, hotel/motel, boarding house, half-
way house.
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tions in the past year were significantly associated with
hospitalization. Frequent hospitalizations for STIs were in turn
associated with years of injection drug use. These findings
highlight a group of patients with repeated hospitalizations for
STIs who, when hospitalized, would be easily accessible to
counselors and targeted interventions.
This study’s finding that injection drug users who lived in a
shelter were 4 times more likely to be hospitalized suggests
that outreach to shelters might impact hospital utilization by
this population. However, the mechanism accounting for this
finding is uncertain. Unstable housing may influence a
physician’s decision to admit a patient, and patients who
reside in shelters may be more willing to be admitted than
those with homes. Specific characteristics of shelters may also
impact the severity of an infection and need for hospitalization.
For example, the close quarters of shelters might foster more
virulent or antibiotic-resistant STI pathogens.
5
Abscess incision and drainage in the operating room rather
than at the bedside was another measure of hospital utiliza-
tion in this study. Nearly a quarter of participants with
abscesses underwent operating room incision and drainage
and the location of an abscess in the shoulder region was the
only independent predictor of operating room incision and
drainage. Shoulder injections are primarily intramuscular and
thus related infections may be deeper and require more
extensive incision and drainage than can be managed at the
bedside.
Previous studies have identified drug use behaviors associ-
ated with developing STIs. A community-based study of
injection drug users found that not cleaning the skin before
injection, subcutaneous or intramuscular injection, and
injecting a combination of heroin and cocaine increased the
risk of developing an abscess.
18 However, in the present study,
these practices were not associated with hospitalization or
operating room incision and drainage. Likewise, previous
studies have suggested that recent incarceration might in-
crease carriage of resistant organisms
19,20 resulting in in-
creased hospitalizations, but we did not find such an
association. Thus, risk factors for STI development and risk
factors for health care utilization among patients seeking care
for STIs in public hospitals appear to be distinct.
Several limitations of this study are noteworthy. It included
only patients who sought care for a STI at 1 hospital’s
Emergency Department and not patients evaluated elsewhere.
The lack of an association between delay in seeking care and
hospitalization in this study may be caused by the fact that
patients with STIs who truly did not delay care were seen
outside the Emergency Department. In addition, the relation-
ship between symptom severity, rapidity of symptom develop-
ment, and the decision to seek care is likely complex and may
not relate to hospitalization in a consistent manner. We
excluded 20 participants who left the Emergency Department
against medical advice or before completion of their medical
evaluation because we were not able to ascertain their true
Emergency Department disposition. If those participants
delayed seeking care and should have been hospitalized, our
primary hypothesis could have been supported. Because we
were not able to collect information from eligible patients who
declined or were not asked to participate, we could not assess
the impact of any recruitment bias. We did not collect specific
information regarding participants’ chronic medical illnesses,
including HIV disease, which might influence infection sever-
ity and need for hospitalization. Lastly, the study may have
lacked the power to detect associations between hospitaliza-
tion or operating room procedures and other factors owing to
small sample size. Its findings should be considered prelimi-
nary and exploratory as no adjustment was made for multiple
comparisons.
Urban public hospitals and their Emergency Departments
bear a disproportionate burden in caring for patients with
complications related to substance abuse and would benefit
most from studies aimed at reducing utilization by this
population. We found that injection drug users who lived in
shelters and who had been injecting for more than 30 years
were more likely to have been hospitalized 2 or more times in
the past year. These data could help target strategies to
reduce the health care utilization resulting from these infec-
tions, and reduce the pain and suffering of this marginalized
population.
Acknowledgment: This research was supported by the Health
Services Research and Development Service, Department of Veter-
ans Affairs; University of Washington Alcohol and Drug Abuse
Institute, and the Robert Wood Johnson Foundation Clinical Scholars
Program. Dr. Takahashi is a staff physician at the VA Puget Sound
Health Care System and is currently supported by the National
Institute on Drug Abuse (NIDA #RO3DA14518). Dr. Baernstein is a
staff physician at Harborview Medical Center. Dr. Binswanger is an
investigator at University of Colorado and was a VA Fellow in the
Robert Wood Johnson Clinical Scholars Program at the University of
Washington at the time this study was conducted. Dr. Bradley is an
investigator at the VA Puget Sound Health Care System and is
currently supported by the National Institute of Alcohol Abuse and
Alcoholism (NIAAA #K23AA00313) and was a Robert Wood Johnson
Foundation Generalist Physician Faculty Scholar at the time this
study was conducted. Dr. Merrill has received funding from Harbor-
view Medical Center in support of this work.
Potential Financial Conflicts of Interest: None disclosed.
Corresponding Author: Traci A. Takahashi, MD, MPH; VA Puget
Sound Health Care System, 1660 S. Columbian Way, Seattle, WA
98108, USA (e-mail: traci@u.washington.edu).
REFERENCES
1. Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High
prevalence of abscesses and cellulitis among community-recruited
injection drug users in San Francisco. Clin Infect Dis. 2000;30
(3):579–81.
2. CDC. Unexplained illness and death among injecting-drug users—
Glasgow, Scotland; Dublin, Ireland; and England, April–June 2000.
MMWR. 2000;49(22):489–92.
3. Lonergan S, Rodriguez RM, Schaulis M, Navaran P. A case series of
patients with black tar heroin-associated necrotizing fasciitis. J Emerg
Med. 2004;26(1):47–50.
4. Charlebois ED, Bangsberg DR, Moss NJ, et al. Population-based
community prevalence of methicillin-resistant Staphylococcus aureus
in the urban poor of San Francisco [see comment]. Clin Infect Dis.
2002;34(4):425–33.
5. Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-
Remington F. High prevalence of methicillin-resistant Staphylococcus
aureus in Emergency Department skin and soft tissue infections. Ann
Emerg Med. 2005;45(3):311–20.
6. Young DM, Harris HW, Charlebois ED, et al. An epidemic of
methicillin-resistant Staphylococcus aureus soft tissue infections
among medically underserved patients. Arch Surg. 2004;139(9):947–
51; discussion 951–3.
387 Takahashi et al.: Injection Drug Users Seeking Care JGIM7. Morgan G, Krishnadasan A, Gorwitz R, et al. Methicillin-resistant S.
aureus infections among patients in the Emergency Department. N Engl
J Med. 2006;355(7):666–74.
8. CDC. Soft tissue infections among injection drug users—San Francisco,
California, 1996–2000. MMWR. 2001;50(19):381–4.
9. Wallace JR, Lucas CE, Ledgerwood AM. Social, economic, and surgical
anatomy of a drug-related abscess. Am Surgeon. 1986;52(7):398–401.
10. Palepu A, Tyndall MW, Leon H, et al. Hospital utilization and costs in a
cohort of injection drug users. CMAJ. 2001;165(4):415–20.
11. Takahashi TA, Merrill JO, Boyko EJ, Bradley KA. Type and location of
injection drug use-related soft tissue infections predict hospitalization. J
Urban Health. 2003;80(1):127–36.
12. Sacks JA, Drake RE, Williams VF, Banks SM, Herrell JM. Utility of the
time-line follow-back to assess substance use among homeless adults. J
Nerv Ment Dis. 2003;191(3):145–53.
13. Hagan H, McGough JP, Thiede H, Hopkins S, Duchin J, Alexander
ER. Reduced injection frequency and increased entry and retention in
drug treatment associated with needle-exchange participation in Seattle
drug injectors. J Subst Abuse Treat. 2000;19(3):247–52.
14. Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin
BR. Sexual transmission of HIV-1 among injection drug users in
San Francisco, USA: risk-factor analysis. Lancet. 2001;357
(9266):1397–401.
15. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA, for the
Ambulatory Care Quality Improvement Project. The AUDIT Alco-
hol Consumption Questions (AUDIT-C): an effective brief screen-
ing test for problem drinking. Arch Intern Med. 1998;158
(16):1789–95.
16. Dawson DA, Grant BF, Stinson FS, Zhou Y. Effectiveness of the derived
Alcohol Use Disorders Identification Test (AUDIT-C) in screening for
alcohol use disorders and risk drinking in the US general population.
Alcohol Clin Exp Res. 2005;29(5):844–54.
17. McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the
addiction severity index. J Subst Abuse Treat. 1992;9(3):199–213.
18. Murphy EL, DeVita D, Liu H, et al. Risk factors for skin and soft-tissue
abscesses among injection drug users: a case-control study. Clin Infect
Dis. 2001;33(1):35–40.
19. Weber JT. Community-associated methicillin-resistant Staphylococcus
aureus. Clin Infect Dis. 2005;41(S4):S269–72.
20. Baillargeon J, Kelley MF, Leach CT, Baillargeon G, Pollock BH.
Methicillin-resistant Staphylococcus aureus infection in the Texas
prison system. Clin Infect Dis. 2004;38(9):e92–5.
388 Takahashi et al.: Injection Drug Users Seeking Care JGIM